Repository logo
 

Structure guided prediction of Pyrazinamide resistance mutations in pncA

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Karmakar, Malancha 
Rodrigues, Carlos HM 
Horan, Kristy 
Denholm, Justin T 

Abstract

Pyrazinamide plays an important role in tuberculosis treatment; however, its use is complicated by side-effects and challenges with reliable drug susceptibility testing. Resistance to pyrazinamide is largely driven by mutations in pyrazinamidase (pncA), responsible for drug activation, but genetic heterogeneity has hindered development of a molecular diagnostic test. We proposed to use information on how variants were likely to affect the 3D structure of pncA to identify variants likely to lead to pyrazinamide resistance. We curated 610 pncA mutations with high confidence experimental and clinical information on pyrazinamide susceptibility. The molecular consequences of each mutation on protein stability, conformation, and interactions were computationally assessed using our comprehensive suite of graph-based signature methods, mCSM. The molecular consequences of the variants were used to train a classifier with an accuracy of 80%. Our model was tested against internationally curated clinical datasets, achieving up to 85% accuracy. Screening of 600 Victorian clinical isolates identified a set of previously unreported variants, which our model had a 71% agreement with drug susceptibility testing. Conclusion: Here, we have shown the 3D structure of pncA can be used to accurately identify pyrazinamide resistance mutations. SUSPECT-PZA is freely available at: http://biosig.unimelb.edu.au/suspect_pza/.

Description

Keywords

Amidohydrolases, Amino Acid Substitution, Antitubercular Agents, DNA Mutational Analysis, DNA, Bacterial, Datasets as Topic, Drug Resistance, Bacterial, Humans, Machine Learning, Microbial Sensitivity Tests, Models, Genetic, Models, Molecular, Mutation, Mycobacterium tuberculosis, Protein Structure, Tertiary, Pyrazinamide, Structure-Activity Relationship, Tuberculosis

Journal Title

Scientific Reports

Conference Name

Journal ISSN

2045-2322
2045-2322

Volume Title

10

Publisher

Nature Publishing Group
Sponsorship
Medical Research Council (MR/M026302/1)
M.K. and C.M.H.R. were funded by the Melbourne Research Scholarship. Funding for genomic sequencing was provided by the Department of Health and Human Services, Victoria. D.B.A. was funded by a Newton Fund RCUK-CONFAP Grant awarded by The Medical Research Council (MRC) and Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) (MR/M026302/1), the Jack Brockhoff Foundation (JBF 4186, 2016), and a C. J. Martin Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (APP1072476). This work was supported in part by the Victorian Government's OIS Program.